期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

视网膜静脉阻塞继发黄斑水肿的治疗进展 被引量：10

Recent advances in anti-angiogenic therapy for macular edema secondary to retinal vein occlusion
下载PDF
导出
摘要 视网膜静脉阻塞是中老年患者常见的眼底血管性疾病,黄斑水肿是导致其视力损害的主要原因。本文综述了目前关于治疗视网膜静脉阻塞继发黄斑水肿的方法及疗效分析,并探讨可能的联合治疗方式。 Retinal vein occlusion is the common neovascular eye disease in the aged,and the macular edema is the main cause of vision loss.This paper reviews the recent advances in therapy of macular edema secondary to retinal vein occlusion,and discusses the possible way of therapeutic alliance.
作者 胡玮婷 孙晓东
机构地区 上海交通大学附属第一人民医院眼科
出处 《眼科新进展》 CAS 北大核心 2011年第8期785-788,共4页 Recent Advances in Ophthalmology
基金 国家重点基础研究发展计划973项目(编号:2011CB707506)~~
关键词 视网膜静脉阻塞 黄斑水肿 抗VEGF治疗 retinal vein occlusion macular edema anti-VEFG treatment
分类号 R774.1 [医药卫生—眼科]
  • 相关文献

参考文献18

  • 1Kelkar AS, Sayyad MG, Kelkar JA, Kelkar SB, Narvankar R, Shaikh A. Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term [ J ]: Indian J Ophthalmol , 2009,57 (3) :243-244.
  • 2CakirM,Dogan M,Bayraktar Z,Bayraktar S,Acar N,Altan T,et al. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation [ J ]. Retina,2008,28 (3) :465-472.
  • 3Pal SA, Shetty R,Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK,et al. Clinical,anatomic,and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion[ J ]. Am J Ophthalmol,2007,143 (4) :601-605.
  • 4Abegg M,Tappeiner C, Wolf-Schnurrbusch U, Barthelmes D, Wolf S,Fleischhauer J. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab [ J ]. BMC Ophthalmol, 2008,8 : 18.
  • 5Raftery J, Clegg A, Jones J, Tan SC, Lotery A. Ranibizumab ( Lucentis) versus bevacizumab ( Avastin ) : modelling cost effectiveness[J]. Br J Ophthalmol,2007,91 (9) :1244-1245.
  • 6孙晓东,宫媛媛,汪枫桦.慎重应用抗新生血管药物治疗视网膜静脉阻塞继发的黄斑水肿[J].中华眼科杂志,2010,46(2):100-102. 被引量：14
  • 7钱彤,黎晓新.玻璃体腔注射曲安奈德后的眼压改变[J].中华眼底病杂志,2007,23(2):115-117. 被引量：35
  • 8Park SP,Ahn JK. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion [ J ]. Clin Experiment Ophthalmol, 2009,37 ( 5 ) : 490-495.
  • 9麻南,贺翔鸽.Bevacizumab与Ranibizumab治疗新生血管性眼病的疗效及安全性的Meta分析[J].中华眼科杂志,2010,46(3):263-267. 被引量：10
  • 10Russo V,Barone A, Conte E,Prascina F,Stella A,Noci ND. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion[ J]. Retina,2009,29(4) :511-515.

二级参考文献46

  • 1王景昭.黄斑水肿的药物和手术治疗[J].中华眼底病杂志,2004,20(5):316-319. 被引量：26
  • 2马进,吴德正,高汝龙,吕林,张少冲,李春芳.糖尿病性黄斑水肿患者玻璃体手术后黄斑区视功能的转归[J].中华眼科杂志,2005,41(3):216-220. 被引量：11
  • 3张惠蓉.视网膜病临床和基础研究[M].山西:山西科学技术出版社,1999.290-291.
  • 4张承芬.视网膜光凝治疗[A].张承芬　主编.眼底病学[C].北京:人民卫生出版社,1998.694-705.
  • 5孙心铨.眼底病的激光治疗[A].张惠蓉　主编.视网膜病临床和基础研究[C].太原:山西科学技术出版社,1998.220，241.
  • 6Rabena MD, Pieramici D J, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina,2007,27:419- 425.
  • 7Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol,2009, 93:452-456.
  • 8Hoeh AE, Aeh T, Schaal KB, et al. Long-term follow-up of OCT- guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, 2009,247 : 1635- 1641.
  • 9Jaissle GB, Leitritz M, Gelisken F, et al. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, 2009, 247:27-33.
  • 10Colquitt JL, Jones J, Tan SC, et al. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess, 2008, 12 : 195-201.

共引文献72

同被引文献75

引证文献10

二级引证文献81

眼科新进展
2011年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部